BSGM - BioSig Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.90
+0.02 (+1.06%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.88
Open1.89
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.80 - 1.91
52 Week Range1.23 - 2.36
Volume92,043
Avg. Volume72,269
Market Cap57.417M
Beta0.56
PE Ratio (TTM)N/A
EPS (TTM)-0.50
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.88
Trade prices are not sourced from all markets
  • GlobeNewswire15 days ago

    BioSig Technologies to Present at the MicroCap Conference

    Santa Monica, CA, April 06, 2018-- BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the ...

  • GlobeNewswire16 days ago

    BioSig Technologies Issues 2018 Shareholder Letter

    Santa Monica, CA, April 05, 2018-- BioSig Technologies, Inc. a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the ...

  • GlobeNewswire24 days ago

    BioSig Announces Submission of FDA 510(k) Application for PURE EP System

    Santa Monica, CA, March 28, 2018-- BioSig Technologies, Inc. announced that the Company has filed 510 application to the U.S. Food and Drug Administration for its first product, PURE EP (TM) System. ...

  • GlobeNewswire24 days ago

    BioSig Announces Submission of FDA 510(k) Application for PURE EP(TM) System

    SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for ...

  • GlobeNewswire24 days ago

    BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System

    SANTA MONICA, Calif., March 28, 2018-- BioSig Technologies, Inc. announced that the Company has filed 510 application to the U.S. Food and Drug Administration for its first product, PURE EP™ System.. PURE ...

  • Zacks Small Cap Research29 days ago

    Recent Insider Buying Activity at BioSig

    Director Patrick Joseph Gallagher bought 20,000 shares of BioSig Technologies stock in a transaction dated Friday, March 9th. The shares were acquired at an average cost of $1.40 per share, for a total transaction of $28,000.00. Director Andrew Lawrence Filler acquired 14,518 shares of the company’s stock in a transaction on Monday, March 19th.

  • GlobeNewswirelast month

    BioSig Technologies Announces Participation in Bates College’s Purposeful Work Initiative

    Santa Monica, CA, March 21, 2018-- BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for ...

  • GlobeNewswirelast month

    Business and Medical Leaders Join BioSig Advisory Board

    Santa Monica, CA, March 20, 2018-- BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the ...

  • GlobeNewswire2 months ago

    BioSig Technologies to Partner with Focus Marketing

    Santa Monica, CA, Feb. 22, 2018-- BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the ...

  • GlobeNewswire2 months ago

    BioSig Technologies to Open Operations Center in Austin, Texas

    Santa Monica, CA, Feb. 13, 2018--. BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for ...

  • ACCESSWIRE4 months ago

    SeeThruEquity Issues Update on BioSig Technologies, Inc. (OTCQB: BSGM)

    NEW YORK, NY / ACCESSWIRE / December 22, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has ...

  • GuruFocus.com5 months ago

    BioSig Technologies Is a Near-Term Biotech Catalyst Play

    A look at what's next for the company

  • BSGM: Bringing Clarity to Catheter Ablation
    Zacks Small Cap Research5 months ago

    BSGM: Bringing Clarity to Catheter Ablation

    When conducting heart studies, interference from nearby equipment can distort the quality of reads and generation of data.  Readings suffer from baseline wander, noise and artifacts, deteriorating the quality of the signal.  The lack of precise data can result in longer procedure duration and the need for additional procedures to address atrial fibrillation (AF) and ventricular tachycardia (VT) given the particular characteristics of these signals.  The PURE EP system is intended to improve the fidelity of cardiac readings for ablation procedures in AF and VT.  It employs signal processing tools to reduce the interference that plagues current diagnostic and recording catheter systems and also higher sampling rates to more accurately represent the raw wave generated.

  • ACCESSWIRE7 months ago

    BioSig Technologies to Present at The MicroCap Conference on October 5th in New York City at the Essex House

    NEW YORK, NY / ACCESSWIRE / September 26, 2017 / BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within ...